The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Patients with Psoriasis, Psoriatic Arthritis at Increased Risk of Migraine

Patients with Psoriasis, Psoriatic Arthritis at Increased Risk of Migraine

October 4, 2015 • By Shannon Aymes

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—Psoriasis and psoriatic arthritis are associated with an increased risk of migraine, according to new research from Denmark.

You Might Also Like
  • Patients with Psoriatic Arthritis at Increased Risk for Type 2 Diabetes
  • Psoriatic Arthritis Linked to Increased Heart Disease Risk
  • Psoriasis Tied to Increased Risk of Major Depression

“The main finding of our study was a psoriasis severity-dependent increased risk of new-onset migraine, and patients with severe skin psoriasis and psoriatic arthritis appeared to have the highest risk,” Dr. Alexander Egeberg from Herlev and Gentofte Hospital in Hellerup told Reuters Health by email.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Thus, focus on migraine in patients with psoriasis, including during cardiovascular risk assessments may be warranted,” he said.

Both psoriasis and migraine have been associated with cardiovascular disease, and their pathophysiological mechanisms may overlap, Dr. Egeberg and colleagues note in the Journal of the American Academy of Dermatology, online Sept. 16

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The researchers collected data on all Danes over 18 from 1997 through 2011 using nationwide registers. During follow-up, they identified 66,080 patients with incident psoriasis and 220,970 with incident migraine.

Psoriasis was classified as mild in 53,006 patients and as severe in 6,831; 6,243 patients had psoriatic arthritis. The migraine incidence rate was 3.86 per 1,000 person-years for the reference population, 5.25 for those with mild psoriasis, 6.41 for those with severe psoriasis and 9.27 for those with psoriatic arthritis.

The fully adjusted rates in mild psoriasis, severe psoriasis and psoriatic arthritis were 1.37, 1.55 and 1.92, respectively, the researchers found. Risks were increased for both men and women.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The authors further note, “the psoriasis severity-dependent increased risk of migraine was independent of measured cardiovascular risk factors, eg, diabetes, hypertension, hyperlipidemia, and socioeconomic status, suggesting that shared pathogenic pathways may be located further upstream or downstream.”

The authors noted several limitations of the study, including inability to determine causality, and the facts that subtypes of migraine with or without aurora were not distinguished and that the Danish population is mostly Caucasian.

The study was supported by a grant from Pfizer. The authors report ties to Pfizer and other drugmakers.

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: Migraine, Psoriasis, Psoriatic Arthritis

You Might Also Like:
  • Patients with Psoriatic Arthritis at Increased Risk for Type 2 Diabetes
  • Psoriatic Arthritis Linked to Increased Heart Disease Risk
  • Psoriasis Tied to Increased Risk of Major Depression
  • Psoriasis, Psoriatic Arthritis Linked with Arrhythmia

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)